For instance, decreased EPHX2 expression has been linked to poor prognosis in liver hepatocellular carcinoma (LIHC) [15], and has been identified as a potential tumor suppressor in cervical squamous cell carcinoma [17]. This evidence concerns the gene EPHX2 and cervical squamous cell carcinoma.